Indo US Bio-TechNSE:INDOUS -0.20%63 Gross Margin % is 29.23% as of Mar. 2026, which is 12% above its 10-year median of 26.17. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.21 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 247 Agriculture companies, Indo US Bio-Tech ranks better than 57.09% on this metric.
The historical rank and industry rank for Indo US Bio-Tech's Gross Margin % or its related term are showing as below:
NSE:INDOUS'
s Gross Margin % Range Over the Past 10 Years
Min: 13.18 Med: 26.17 Max: 32.32
Current: 27.32
During the past 13 years, the highestGross Margin % of Indo US Bio-Tech was 32.32%. The lowest was 13.18%. And the median was 26.17%.
NSE:INDOUS's Gross Margin % is ranked better than 57.09% of 247
companies
in the Agriculture industry
Industry Median: 24.81
vs NSE:INDOUS: 27.32
Indo US Bio-Tech had a gross margin of 29.23% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Indo US Bio-Tech was -1.00% per year.
Indo US Bio-Tech (NSE:INDOUS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Indo US Bio-Tech had a gross margin of 29.23% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Indo US Bio-Tech Gross Margin % Related Terms
Indo US Bio-Tech Gross Margin % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: Gross Margin % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech Gross Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Indo US Bio-Tech (NSE:INDOUS) has a Gross Margin % of 29.23% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Indo US Bio-Tech and its competitors. This is 12% above median its historical median of 26.17. Over the past decade, Indo US Bio-Tech's Gross Margin % has ranged from 13.18 to 32.32. According to the industry distribution chart, Indo US Bio-Tech ranks #106 out of 247 companies in the Agriculture industry, placing it in the top 42.9%.
Is Indo US Bio-Tech's Gross Margin % too high?
Indo US Bio-Tech's current Gross Margin % of 29.23% is 12% above median its 10-year median of 26.17. Over the past 10 years, this metric has ranged from a low of 13.18 to a high of 32.32. The Agriculture industry median Gross Margin % is 24.81. Indo US Bio-Tech's value of 29.23% is 17.8% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #106 out of 247 companies in the Agriculture industry, which is above the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Gross Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #106 out of 247 companies for Gross Margin %. This puts Indo US Bio-Tech in the upper half of its industry. The industry median Gross Margin % is 24.81. Indo US Bio-Tech's value of 29.23% is 17.8% above this benchmark. Historically, Indo US Bio-Tech's own Gross Margin % has ranged from 13.18 to 32.32 over the past decade. While the company's 10-year median is 26.17 vs. the industry median of 24.81, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for an Agriculture company?
The median Gross Margin % among Agriculture companies is 24.81, based on 247 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current Gross Margin % of 29.23% is 17.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median Gross Margin % is 24.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current Gross Margin % is 29.23%, which is 12% above median its own 10-year median of 26.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.21, compared to a current price of ₹88.30 — trading 55.5% below its estimated fair value. The current Gross Margin % is 29.23%, which is 12% above median its 10-year median of 26.17 and 17.8% above the Agriculture industry median of 24.81. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Gross Margin % is 29.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹88.30 is trading 55.5% below its estimated GF Value™ of ₹198.21.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
Gross Margin %: 29.23% (12% above median its 10-year median of 26.17)
GF Value™: ₹198.21 vs. price of ₹88.30 (55.5% below fair value)
Industry Position: 17.8% above the Agriculture median (#106 of 247)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score
Get the complete analysis for NSE:INDOUS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
